Evidence map›Paper›PMID 42910210›Full record

ArticleKidney diseases (Basel, Switzerland)

Predictors of Balloon-Assisted Arteriovenous Fistula Maturation: Importance of Intervention Timing and Blood Flow.

Ziming Wan, Hongwei Yang, Qiquan Lai, Xuejing Gao, Ling Chen, Xi Zhang, Hua Gan

Abstract read
In one paragraph

Article in Kidney diseases (Basel, Switzerland). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ziming WanDepartment of Nephrology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Hongwei YangDepartment of Nephrology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Qiquan LaiDepartment of Nephrology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Xuejing GaoDepartment of Nephrology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Ling ChenDepartment of Nephrology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Xi ZhangDepartment of Nephrology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Hua GanDepartment of Nephrology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Balloon-assisted maturation (BAM) improves the success rate of arteriovenous fistula (AVF) creation. However, the optimal timing of BAM and the factors influencing its success remain unclear. This study aimed to evaluate the clinical success rate of BAM and identify related influencing factors. Methods: A total of 991 patients undergoing BAM due to AVF immaturity were included (2017-2023) in this study. Data on patient demographics, AVF characteristics, procedural details, brachial artery ultrasound parameters, and preoperative serological indicators were collected. Logistic regression analyses identified factors associated with functional maturation. Results: The overall assisted maturation rate was 94.15%. An AVF creation-to-BAM interval of <90 days (odds ratio [OR] = 0.413, Conclusion: BAM is an effective intervention for immature AVFs. A longer interval from AVF creation to BAM and higher postoperative brachial flow are associated with increased AVF maturation rates, especially in younger patients.

Indexed as

Arteriovenous fistulaBalloon-assisted maturationInfluencing factorMaturation failure

Identifiers

PMID42910210
PMCPMC13685595

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.